Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Sucrose in Acute Decompensated HFrEF with Iron Deficiency
NCT06703411Phase 4Completed
- Sponsor
- Cheng Hsin General Hospital
- Start
- May 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in iron deficiency anemia (IDA) comparing Iron sucrose with Standard of care (2 arms). Primary endpoint: Kansas City Cardiomyopathy Questionnaire Score at 4 weeks. Started May 2023; status: completed.
02
Drugs
iron sucrose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06703411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06703411.